Serum levels of soluble CD163 in patients with systemic sclerosis

Rheumatology International

Volumn 32, Issue 2, 2012, Pages 403-407

  Nakayama, Wakana ^a   Jinnin, Masatoshi ^a   Makino, Katsunari ^a   Kajihara, Ikko ^a   Makino, Takamitsu ^a   Fukushima, Satoshi ^a   Inoue, Yuji ^a   Ihn, Hironobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Collagen disease; Fibrosis; Macrophage; Pulmonary hypertension

Indexed keywords

BIOLOGICAL MARKER; CD163 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HEART RIGHT VENTRICLE PRESSURE; HUMAN; MACROPHAGE; MALE; PATHOGENESIS; PRIORITY JOURNAL; SCHOOL CHILD; SYSTEMIC SCLEROSIS;

AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; FEMALE; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; SCLERODERMA, SYSTEMIC; SOLUBILITY;

EID: 84857052294     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1691-z     Document Type: Article

References (30)

1. O Ishikawa H Ishikawa 1992 Macrophage infiltration in the skin of patients with systemic sclerosis J Rheumatol 19 1202 1206 1404154 1:STN:280:DyaK3s%2FitVyitg%3D%3D
2. Varga J (2004) Pathogenesis: emphasis on human data. In: Clements PJ (ed) Systemic sclerosis, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 63-97
3. S Gordon 2003 Alternative activation of macrophages Nat Rev Immunol 3 23 35 12511873 10.1038/nri978 1:CAS:528:DC%2BD3sXovVw%3D (Pubitemid 37328697)
4. N Higashi-Kuwata T Makino Y Inoue M Takeya H Ihn 2009 Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma Exp Dermatol 18 727 729 19320738 10.1111/j.1600-0625.2008.00828.x
5. D Mosser 2003 The many faces of macrophage activation J Leukoc Biol 73 209 212 12554797 10.1189/jlb.0602325 1:CAS:528:DC%2BD3sXhtF2lur0%3D (Pubitemid 36158295)
6. A Mantovani A Sica S Sozzani P Allavena A Vecchi M Locati 2004 The chemokine system in diverse forms of macrophage activation and polarization Trends Immunol 25 677 686 15530839 10.1016/j.it.2004.09.015 1:CAS:528: DC%2BD2cXptl2ktbs%3D (Pubitemid 39457982)
7. Y Komohara J Hirahara T Horikawa K Kawamura E Kiyota N Sakashita, et al. 2006 AM-3 K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype J Histochem Cytochem 54 763 771 16517975 10.1369/jhc.5A6871.2006 1:CAS:528:DC%2BD28Xmt1eisbc%3D (Pubitemid 43946243)
8. F Martinez S Gordon M Locati A Mantovani 2006 Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression J Immunol 177 7303 7311 17082649 1:CAS:528:DC%2BD28XhtFGrtrbM (Pubitemid 44715100)
9. V Kodelja C Müller S Tenorio C Schebesch C Orfanos S Goerdt 1997 Differences in angiogenic potential of classically vs alternatively activated macrophages Immunobiology 197 478 493 9413747 10.1016/S0171-2985(97)80080-0 1:STN:280:DyaK1c%2FnsFKlug%3D%3D (Pubitemid 27489996)
10. G Raes A Beschin G Ghassabeh P De Baetselier 2007 Alternatively activated macrophages in protozoan infections Curr Opin Immunol 19 454 459 17628461 10.1016/j.coi.2007.05.007 1:CAS:528:DC%2BD2sXpsFKkt7o%3D (Pubitemid 47284853)
11. M Nielsen M Madsen H Møller S Moestrup 2006 The macrophage scavenger receptor CD163: endocytic properties of cytoplasmic tail variants J Leukoc Biol 79 837 845 16434690 10.1189/jlb.1005602 1:CAS:528: DC%2BD28XjsFClsr8%3D (Pubitemid 44835616)
12. B Raychaudhuri T Bonfield A Malur K Hague M Kavuru A Arroliga, et al. 2002 Circulating monocytes from patients with primary pulmonary hypertension are hyporesponsive Clin Immunol 104 191 198 12165280 10.1006/clim.2002.5253 1:CAS:528:DC%2BD38XnvFCmtLo%3D (Pubitemid 35026229)
13. L Sakkas I Chikanza C Platsoucas 2006 Mechanisms of disease: the role of immune cells in the pathogenesis of systemic sclerosis Nat Clin Pract Rheumatol 2 679 685 17133253 10.1038/ncprheum0346 1:CAS:528:DC%2BD28XhtlentL3K (Pubitemid 44830857)
14. H Maricq A McGregor F Diat E Smith D Maxwell E LeRoy, et al. 1990 Major clinical diagnoses found among patients with Raynaud phenomenon from the general population J Rheumatol 17 1171 1176 2290157 1:STN:280:DyaK3M7kvVSmtA%3D%3D (Pubitemid 20334694)
15. D Baeten H Møller J Delanghe E Veys S Moestrup F De Keyser 2004 Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis Arthritis Rheum 50 1611 1623 15146432 10.1002/art.20174 (Pubitemid 38608084)
16. A Hiraoka N Horiike S Akbar K Michitaka T Matsuyama M Onji 2005 Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure J Gastroenterol 40 52 56 15692789 10.1007/s00535-004-1493-8 1:CAS:528:DC%2BD2MXhtVamsbs%3D (Pubitemid 40796332)
17. K Kawamura Y Komohara K Takaishi H Katabuchi M Takeya 2009 Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors Pathol Int 59 300 305 19432671 10.1111/j.1440-1827. 2009.02369.x
18. N Matsushita M Kashiwagi R Wait R Nagayoshi M Nakamura T Matsuda, et al. 2002 Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3 Clin Exp Immunol 130 156 161 12296867 10.1046/j.1365-2249.2002.01963.x 1:CAS:528:DC%2BD38XotlGgs7o%3D
19. E LeRoy C Black R Fleischmajer S Jablonska T Krieg TJ Medsger, et al. 1988 Scleroderma (systemic sclerosis): classification, subsets and pathogenesis J Rheumatol 15 202 205 3361530 1:STN:280:DyaL1c3gtVWnsg%3D%3D (Pubitemid 18073738)
20. H Ihn S Sato M Fujimoto K Kikuchi A Igarashi Y Soma, et al. 1996 Measurement of anticardiolipin antibodies by ELISA using β2-glycoprotein I (β 2-GPI) in systemic sclerosis Clin Exp Immunol 105 475 479 8809137 10.1046/j.1365-2249.1996.d01-774.x 1:CAS:528:DyaK28XmtFWht7c%3D (Pubitemid 26297893)
21. H Ihn S Sato T Tamaki Y Soma T Tsuchida Y Ishibashi, et al. 1992 Clinical evaluation of scleroderma spectrum disorders using a points system Arch Dermatol Res 284 391 395 1288419 10.1007/BF00372068 1:STN:280: DyaK3s7msl2ntQ%3D%3D (Pubitemid 23009895)
22. H Maricq M Weinrich J Keil E Smith F Harper A Nussbaum, et al. 1989 Prevalence of scleroderma spectrum disorders in the general population of South Carolina Arthritis Rheum 32 998 1006 2788424 10.1002/anr.1780320809 1:STN:280:DyaL1MzltFWitA%3D%3D (Pubitemid 19218379)
23. K Yamane H Ihn Y Asano N Yazawa M Kubo K Kikuchi, et al. 2000 Clinical and laboratory features of scleroderma patients with pulmonary hypertension Rheumatology 39 1269 1271 11085808 10.1093/rheumatology/39.11.1269 1:STN:280:DC%2BD3M%2FmtlKiuw%3D%3D
24. S Proudman W Stevens J Sahhar D Celermajer 2007 Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment Intern Med J 37 485 494 17547726 10.1111/j.1445-5994.2007.01370.x 1:STN:280:DC%2BD2szjsFynsA%3D%3D (Pubitemid 46855082)
25. Mathai S, Gulati M, Peng X, Russell T, Shaw A, Rubinowitz A et al. (2010) Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest (in press)
26. T Sugita K Stenmark WJ Wagner P Henson J Henson T Hyers, et al. 1983 Abnormal alveolar cells in monocrotaline induced pulmonary hypertension Exp Lung Res 5 201 215 6418536 10.3109/01902148309061515 1:CAS:528:DyaL2cXkt1Gm (Pubitemid 14202176)
27. K Abe H Shimokawa K Morikawa T Uwatoku K Oi Y Matsumoto, et al. 2004 Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats Circ Res 94 385 393 14670839 10.1161/01.RES.0000111804.34509.94 1:CAS:528:DC%2BD2cXhtFWlu7o%3D (Pubitemid 38240731)
28. 2-induced pulmonary hypertension in the neonatal rat Pediatr Res 50 172 183 11477200 10.1203/00006450-200108000-00003 1:CAS:528:DC%2BD3MXmtVynuro%3D (Pubitemid 32701189)
29. C Denton J Cailes G Phillips A Wells C Black R Bois 1997 Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis Br J Rheumatol 36 239 243 9133938 10.1093/rheumatology/36.2.239 1:STN:280:DyaK2s3nvFCqtQ%3D%3D
30. T Sulahian K Hintz K Wardwell P Guyre 2001 Development of an ELISA to measure soluble CD163 in biological fluids J Immunol Methods 252 25 31 11334962 10.1016/S0022-1759(01)00328-3 1:CAS:528:DC%2BD3MXjtFGjtrk%3D (Pubitemid 32382087)